
==== Front
BMC Musculoskelet Disord
BMC Musculoskelet Disord
BMC Musculoskeletal Disorders
1471-2474
BioMed Central London

7811
10.1186/s12891-024-07811-5
Research
Preoperative low serum albumin increases the rate of perioperative blood transfusion in patients undergoing total joint arthroplasty: propensity score matching
Xu Shenglian 1
Xiong Xiaojuan 1
Li Ting 1
Hu Peng 2
Mao Qingxiang qxmao@tmmu.edu.cn

1
1 grid.414048.d 0000 0004 1799 2720 Department of Anesthesiology, Army Medical Center of PLA, Daping Hospital, Army Medical University, 10 ChangjiangZhilu, Yuzhong District, Chongqing, 400042 People’s Republic of China
2 https://ror.org/023rhb549 grid.190737.b 0000 0001 0154 0904 School of Public Policy and Administration, Chongqing University, 174 shazheng street, Shapingba District, Chongqing, 400044 China
2 9 2024
2 9 2024
2024
25 69517 4 2024
22 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

To investigate the relationship between preoperative low serum albumin and perioperative blood transfusion in patients undergoing total joint arthroplasty (TJA).

Methods

We enrolled 2,772 TJA patients from our hospital between January 1, 2017, and January 1, 2022. Clinical data were extracted from electronic medical records, including patient ID, sex, BMI (Body Mass Index), age, and diagnoses. Receiver operating characteristic curves were constructed to establish thresholds for serum albumin levels categorization. Propensity score matching (PSM) was developed with preoperative serum albumin as the dependent variable and perioperative blood transfusion-related factors as covariates, including BMI grade, age grade, sex, diagnosis, hypertension, diabetes, coronary heart disease, chronic obstructive pulmonary disease, chronic bronchitis, cerebral infarction, major surgeries within the last 12 months, renal failure, cancer, depression, corticosteroid use, smoking, drinking, and blood type. The low serum albumin group was matched with the normal albumin group at a 1:2 ratio, employing a caliper value of 0.2. Binary logistic regression was employed to analyze the outcomes.

Results

An under the curve of 0.601 was discovered, indicating a cutoff value of 37.3 g/L. Following PSM, 892 cases were successfully paired in the low serum (< 37.3 g/L) albumin group, and 1,401 cases were matched in the normal serum albumin (≥ 37.3 g/L) group. Binary logistic regression in TJA patients showed that the albumin OR was 0.911 with 95%CI 0.888–0.935, P < 0.001. Relative to the preoperative normal serum albumin group, TJA patients in the low serum albumin group experienced a 1.83-fold increase in perioperative blood transfusion rates (95% CI 1.50–2.23, P < 0.001). Compared to the normal serum albumin group, perioperative blood transfusion rates for TJA patients with serum albumin levels of 30–37.3 g/L, 25–30 g/L, and ≤ 25 g/L increased by 1.63 (95% CI 1.37–1.99, P < 0.001), 5.4 (95% CI 3.08–9.50, P < 0.001), and 6.43 times (95% CI 1.80-22.96, P = 0.004), respectively.

Conclusion

In TJA patients, preoperative low serum albumin levels have been found to be associated with an increased risk of perioperative blood transfusion. Furthermore, it has been observed that the lower the preoperative serum albumin level is, the higher the risk of perioperative blood transfusion.

Trial registration

28/12/2021, Chinese Clinical Trial Registry, ChiCRT2100054844.

Keywords

Blood transfusion
Total joint arthroplasty
Low serum albumin
Preoperative
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Total joint arthroplasty (TJA), encompassing total hip arthroplasty (THA) and total knee arthroplasty (TKA), is a surgical procedure that aims to relieve pain, improve function, and correct deformity [1]. With the aging of the population, the number of TJA surgeries is expected to increase by 174 to 673% by 2030 [2, 3], leading to greater blood loss and a higher demand for transfusion [4]. In China, the annual growth rate of primary THA is 25 to 30% [5], while in the United States, orthopedic surgery accounts for 10% of all red blood cell transfusions in a year, with 39% used for TJA patients [6]. Pennestrì reported that 12 to 22% of patients required transfusion in THA and TKA [7], while Menendez found that the transfusion rate of TKA was as high as 11%, and that of THA was as high as 15.9% [8]. Although the perioperative transfusion rate in TJA patients remains high, transfusion can increase the risk of perioperative complications [9–11]. Engoren revealed that blood transfusion in THA patients was linked with an increased risk of mortality within 90 days post-surgery [9]. Carson found that transfusion increased the risk of severe bacterial infection by 35% and the risk of pneumonia by 52% in THA patients [10]. In a large retrospective transfusion in noncardiac surgery increased by 29%, and the chances of pulmonary, septic, wound, or thromboembolic complications increased by 40–90% [11].

Additional allogeneic blood transfusions are an effective way to improve anemia status but raise concerns regarding viral transmission, possible immunosuppression and transfusion reactions [12]. Xiong highlighted preoperative anemia as a significant risk factor for perioperative transfusion in TJA patients [13]. Moreover, they found a direct correlation between the severity of preoperative anemia and the increased likelihood of requiring transfusion during the perioperative period [13]. Malnutrition is also considered a significant contributor to preoperative anemia among TJA patients [13]. Albumin, a key serum protein, is a widely utilized marker for assessing nutritional status [14]. Composing approximately 80% of the colloid osmotic pressure in plasma, albumin facilitates drug and endogenous compound transport, serves as an effective plasma buffer, possesses notable antioxidant capabilities, and supports microvasculature integrity [15, 16]. Currently, only a restricted number of studies have investigated the correlation between preoperative albumin levels and perioperative transfusion among TJA patients [17–19]. Cavazos noted that preoperative hypoalbuminemia increased the perioperative transfusion rate in TKA patients [17]. Hur further highlighted those patients with hypoalbuminemia had a fourfold higher probability of perioperative transfusion in unicompartmental knee arthroplasty (UKA) [18].

Numerous contemporary studies highlight the impact of preoperative low albumin levels and perioperative transfusions on postoperative complications of TJA. However, the association between serum albumin reduction and transfusion remains inadequately explored. In this study, we proposed the following hypothesis: the decrease in preoperative serum albumin levels is associated with a higher probability of requiring perioperative transfusion in TJA patients. Furthermore, we anticipated that a lower preoperative serum albumin level would lead to a higher risk of perioperative transfusion.

Materials and methods

Inclusion and exclusion criteria

Inclusion

All patients who received TJA from January 1, 2,017, to January 1, 2,022 in our hospital.

Exclusion

Patients who had no preoperative liver function test records; and patients with tumors or tuberculosis (Fig. 1).

Fig. 1 Research scheme of PSM analysis of Low albumin group and Normal albumin group in TJA patients. AUC: areas under the curve; CI: confidence interval; TJA: total joint arthroplasty; P < 0.05 was considered statistically significant

Research method

Receiver operating characteristic (ROC) curves were constructed to establish thresholds for serum albumin levels categorization. TJA patients with documented blood transfusions (primarily red blood cell transfusions) were assigned to the transfusion group, while those who did not receive transfusions during the perioperative period constituted the non-transfusion group. Subsequently, we conducted a multivariate binary logistic regression analysis to examine the results. This study has been approved by the Ethics Committee of Army Medical Center of PLA of the authors’ affiliated.

Data collection

We retrieved clinical information for our study from the electronic medical records system. Our data collection primarily focused on patients’ hospital identification numbers, sex, body mass index (BMI), age, and diagnoses (including osteoarthritis [OA], rheumatoid arthritis [RA], and bone fractures). Additionally, we documented any preexisting comorbidities among the patients, such as coronary heart disease (CHD), chronic bronchitis, diabetes, hypertension, cerebral infarction, cancer, renal failure, corticosteroid use, chronic obstructive pulmonary disease (COPD), alcohol consumption, smoking, and any major surgeries within the past 12 months. Furthermore, we conducted laboratory tests, including ABO blood typing (AB, A, O, B) and liver function (serum total protein, albumin, globulin) analyses, and recorded instances of blood transfusion during surgery.

Data analyses

We conducted statistical analysis using SPSS 26.0 software (IBM Corp., Armonk, NY, USA). For categorical data, we employed Chi-square tests or Fisher’s exact tests, expressing the results as percentages (%). To account for confounding factors, we established a logistic regression model using propensity score matching (PSM). The model used preoperative serum albumin as the dependent variable and included covariates such as BMI grade, age grade, sex, diagnosis, hypertension, diabetes, coronary heart disease, chronic obstructive pulmonary disease, chronic bronchitis, cerebral infarction, major surgeries within the last 12 months, renal failure, cancer, depression, corticosteroid use, smoking, drinking, and blood type, along with perioperative blood transfusion-related variables. We matched the normal serum albumin and the low serum albumin group at a ratio of 2:1, with a caliper value of 0.2. We assessed the PSM’s matching effectiveness using the standardized difference method. Subsequently, we conducted binary logistic regression analysis on both groups, computing the adjusted odds ratio (OR) and 95% confidence interval (CI) to explore the relationship between preoperative serum albumin levels, severity of low serum albumin, and perioperative blood transfusion, as well as transfusion volume in TJA patients. During our analysis, we addressed multicollinearity, particularly between low serum albumin, perioperative blood transfusion, and albumin reduction. The VIF between low serum albumin and severity of low serum albumin was 6.404, with a tolerance of 0.156. Although these values do not indicate severe multicollinearity (VIF > 10, tolerance < 0.05), they suggest a notable degree. Therefore, we conducted separate logistic regression analyses for these two variables to ensure reliable results. A significance level of P < 0.05 was used to denote statistical significance.

Results

Patients’ baseline characteristics

Based on the ROC curve constructed using preoperative serum albumin levels and the perioperative blood transfusion rate, we identified an area under the curve (AUC) of 0.601 (P < 0.001, 95% CI 0.573–0.629), with an albumin cutoff value of 37.3 g/L (Fig. 2). Among the 2,772 TJA patients, 2,462 patients were enrolled. The mean age of the TJA patients was 63.54 ± 11.71 years (Table 1). There were 924 men patients and 1,538 women patients. Among them, there were 1,131 patients with OA, 1,003 with RA, and 328 with fractures (Table 2). Notably, 939 (38.16%) of our patients exhibited serum albumin levels below 37.3 g/L.

Fig. 2 Diagnostic performances of the serum albumin for predicting perioperative blood transfusion among TJA patients. OR: Odds ratio; PSM: propensity score matching; TJA: total joint arthroplasty; CI: confidence interval; P < 0.05 was considered statistically significant

Table 1 Baseline characteristics of the patients before PSM

	Low albumin group (939)	Normal albumin group (1523)	P	
Height (cm)	158.09±7.89	158.24±8.39	0.66	
Weight (kg)	59.79±9.87	62.02±10.68	< 0.001	
BMI (kg/m2)	23.93±3.65	24.8±4.49	< 0.001	
Age (year)	65.58±10.84	62.27±12.04	< 0.001	
TP (g/L)	61.88±5.46	67.44±5.12	< 0.001	
Albumin (g/L)	34.4±2.66	40.4±2.49	< 0.001	
Globulin (g/L)	27.49±5.19	27.12±4.13	0.062	
BMI: Body Mass Index; CHD; Coronary heart disease; PSM: propensity score matching; TJA: total joint arthroplasty; TP: Total serum protein; P< 0.05 was considered statistically significant

Comparison of perioperative blood transfusion-related variables before and after PSM in TJA patients

Before PSM, we meticulously matched several variables, including BMI grade, age grade, sex, diagnosis, hypertension, diabetes, CHD, COPD, chronic bronchitis, cerebral infarction, major surgeries within the last 12 months, renal failure, cancer, depression, corticosteroid use, smoking, drinking, and blood type. Among the 18 indicators, significant differences emerged in BMI grade (P < 0.001), age grade (P < 0.001), hypertension (P = 0.001), renal failure (P = 0.001), and corticosteroid use (P < 0.001) across the groups. Subsequently, following successful PSM matching, we achieved 892 matched pairs in the low serum albumin group and 1401 matched pairs in the normal serum albumin group. Significantly, the P values for all 18 variables were above 0.05, suggesting no statistically significant differences between the two datasets. This outcome underscored the comparative balance achieved through PSM, demonstrating the comparability of the groups (Table 2).

Table 2 Distribution characteristics of covariates in TJA patients before and after PSM in low albumin group and normal albumin group

Covariates	Before matching (n=2462)	After matching (n=2292)	
Low albumin (939)	Normal albumin (1523)	χ2	P	Low albumin (892)	Normal albumin (1401)	χ2	P	
BMI grade (kg/m2)					22.10	<0.001					1.85	0.18	
 <18.5	53	5.64%	41	2.69%			37	4.15%	41	2.93%			
 18.5-24.9	535	56.98%	815	53.51%			512	57.40%	773	55.17%			
 25-29.9	298	31.74%	544	35.72%			290	32.51%	487	34.76%			
 ≥30	53	5.64%	123	8.08%			53	5.94%	100	7.14%			
Age grade					22.80	<0.001					0.20	0.659	
 ≥60 years	680	72.42%	961	63.10%			643	72.09%	917	65.45%			
 <60 years	259	27.58%	562	36.90%			249	27.91%	484	34.55%			
Genter					1.97	0.09					0.53	0.4	
 Men	369	39.30%	555	36.44%			346	38.79%	525	37.47%			
 Women	570	60.70%	968	63.56%			546	61.21%	876	62.53%			
Diagnosis					5.57	0.06					1.26	0.53	
 OA	427	45.47%	704	46.22%			404	45.29%	641	45.75%			
 RA	368	39.19%	635	41.69%			359	40.25%	580	41.40%			
 Fracture	144	15.34%	184	12.08%			129	14.46%	180	12.85%			
Hypertension					10.40	0					3.59	0.06	
 Yes	232	24.71%	468	30.73%			228	25.56%	409	29.19%			
 No	707	75.29%	1055	69.27%			664	74.44%	992	70.81%			
Diabetes					3.35	0.07					1.29	0.26	
 Yes	86	9.16%	175	11.49%			86	9.64%	156	11.13%			
 No	853	90.84%	1348	88.51%			806	90.36%	1254	89.51%			
CHD					0.01	0.95					0.05	0.83	
 Yes	50	5.32%	82	5.38%			49	5.49%	80	5.71%			
 No	889	94.68%	1441	94.62%			843	94.51%	1321	94.29%			
COPD					0.19	0.66					0.18	0.68	
 Yes	15	1.60%	21	1.38%			14	1.57%	19	1.36%			
 No	924	98.40%	1502	98.62%			878	98.43%	1382	98.64%			
Chronic bronchitis					0.23	0.64					0.19	0.66	
 Yes	12	1.28%	23	1.51%			12	1.35%	22	1.57%			
 No	927	98.72%	1500	98.49%			880	98.65%	1379	98.43%			
Cerebral infarction					1.05	0.31					0.92	0.34	
 Yes	30	3.19%	38	2.50%			29	3.25%	36	2.57%			
 No	909	96.81%	1485	97.50%			863	96.75%	1365	97.43%			
Major surgery in the last 12 months			0.29	0.59					0.22	0.88	
 Yes	34	3.62%	49	3.22%			29	3.25%	44	3.14%			
 No	905	96.38%	1474	96.78%			863	96.75%	1357	96.86%			
Renal failure					8.32	0					0.94	0.38	
 Yes	10	1.06%	3	0.20%			3	0.34%	2	0.14%			
 No	929	98.94%	1520	99.80%			889	99.66%	1399	99.86%			
Cancer					0.13	0.72					0.08	0.77	
 Yes	8	0.85%	11	0.72%			8	0.90%	11	0.79%			
 No	931	99.15%	1512	99.28%			884	99.10%	1390	99.21%			
Depression					3.09	0.08				0.00%			
 Yes	0	0.00%	5	0.33%			*		*				
 No	939	100.00%	1518	99.67%			*		*				
Corticosteroid					22.18	<0.001		0.00%		0.00%	1.82	0.18	
 Yes	43	4.58%	22	1.44%			21	2.35%	22	1.57%			
 No	893	95.10%	1501	98.56%			871	97.65%	1379	98.43%			
Smoking					0.90	0.36		0.00%			0.05	0.94	
 Yes	156	16.61%	231	15.17%			143	16.03%	223	15.92%			
 No	783	83.39%	1292	84.83%			749	83.97%	1178	84.08%			
Drinking					0.10	0.76		0.00%			0.02	0.97	
 Yes	140	14.91%	220	14.45%			133	14.91%	208	14.85%			
 No	799	85.09%	1303	85.55%			759	85.09%	1193	85.15%			
Blood type					4.23	0.24		0.00%			1.32	0.72	
 type A	293	31.20%	512	33.62%			279	31.28%	458	32.69%			
 type B	233	24.81%	404	26.53%			224	25.11%	366	26.12%			
 type AB	336	35.78%	490	32.17%			314	35.20%	467	33.33%			
 type O	77	8.20%	117	7.68%			75	8.41%	110	7.85%			
BMI: Body Mass Index; CHD; Coronary heart disease; COPD: chronic obstructive pulmonary disease; TJA: total joint arthroplasty; OA: Osteoarthritis; OR: Odds ratio; PSM: propensity score matching; RA: Rheumatoid Arthritis; P< 0.05 was considered statistically significant

Correlation between the extent of preoperative serum albumin reduction and perioperative blood transfusion in TJA patients

There were 568 cases of perioperative blood transfusion, accounting for 23.08% of TJA patients. In the normal serum albumin group, the transfusion rate was 18.9%, while in the low albumin group, it was 29.54%. The transfusion rate increased from 18.9% in the normal albumin group to 60% in the low albumin group (≤ 25 g/L). Both before and after PSM, as the preoperative serum albumin level decreased, the perioperative blood transfusion rate of TJA patients gradually increased (Table 3).

Table 3 The degree of low serum albumin and the incidence of perioperative blood transfusion in TJA patients before and after PSM

Blood transfusion	Normal albumin
≥ 37.3 g/L	Low albumin classification	Total	
37.2–30 g/L	30–25 g/L	≤ 25 g/L	
Before PSM	1545(287)	18.58%	851(243)	28.55%	54(31)	57.40%	12(7)	58.33%	2462(568)	23.08%	
After PSM	1423(269)	18.90%	808(222)	27.46%	52(29)	55.77%	10(6)	60.00%	2293(526)	27.48%	
PSM: propensity score matching; TJA: total joint arthroplasty; TP: Total serum protein; P < 0.05 was considered statistically significant

The correlation between the severity of hpreoperative low albumin levels and perioperative blood transfusions in TJA patients

After PSM, we discovered the relationship between albumin values and perioperative blood transfusion, yielding an OR for albumin of 0.911 and a 95% CI of (0.888, 0.935), P < 0.001. As every 1 g increase in preoperative serum albumin levels, the likelihood of perioperative blood transfusion decreases by 0.911 times. Based on the cutoff value for serum albumin, we categorized the patients into the normal serum albumin group (≥ 37.3 g/L) and the low serum albumin group (< 37.3 g/L). Binary logistic regression analysis revealed that, for TJA patients, the perioperative transfusion rate in the low serum albumin group increased by 1.83 times in comparison to the preoperative normal serum albumin group, exhibiting a 95% CI of (1.50–2.23), P < 0.001 (Fig. 3).

Fig. 3 Binary logistic regression analysis of preoperative low serum albumin and perioperative blood transfusion in TJA patients after PSM. OR: Odds ratio; PSM: propensity score matching; TJA: total joint arthroplasty; CI: confidence interval; P < 0.05 was considered statistically significant

Patients were classified on the basis of serum albumin levels into four groups: ≥37.3 g/L, 30–37.3 g/L, 25–30 g/L, and ≤ 25 g/L. Post-PSM, among TJA patients, when compared to those in the preoperative serum albumin group ≥ 37.3 g/L, the transfusion rates during the perioperative period increased by 1.63 times (95% CI: 1.37–1.99, P < 0.001), 5.41 times (95% CI: 3.08–9.50, P < 0.001), and 6.43 times (95% CI: 1.80-22.96, P = 0.004), respectively, in the 30–37.3 g/L, 25–30 g/L, and ≤ 25 g/L serum albumin groups (Fig. 4).

Fig. 4 Binary logistic regression analysis of the degree of preoperative low serum albumin and perioperative blood transfusion in TJA patients after PSM

Discussion

We utilized ROC curves to identify the cutoff value of preoperative serum albumin at 37.3 g/L for perioperative blood transfusions in TJA patients. As every 1 g increase in preoperative serum albumin levels, the likelihood of perioperative blood transfusion decreases by 0.911 times among TJA patients. Furthermore, we found that, compared to the normal serum albumin group, the overall perioperative transfusion rate increased by 1.83 times in the low albumin group among TJA patients. Additionally, in TJA patients, the perioperative transfusion rate increased by 1.63 times, 5.41 times, and 6.43 times in the 30–37.3 g/L, 25–30 g/L, and ≤ 25 g/L serum albumin groups, respectively, compared to the preoperative ≥ 37.3 g/L serum albumin group (Fig. 4). In summary, our study indicates that TJA patients with lower preoperative serum albumin levels are at an increased risk of perioperative blood transfusion.

The connection between reduced serum albumin and perioperative blood transfusion

Traditionally, serum albumin levels < 35 g/L are set as the sole parameter for malnutrition [20], yet the cutoff value of 37.3 g/L in our study is higher than the traditional threshold of malnutrition. Black discovered that albumin levels below 35 g/L increase the risk of 90-day readmission by 1.5 times in TJA patients [21]. They suggested that an albumin threshold of 35 g/L might not identify some high-risk patients and proposed an optimal albumin threshold of 39.4 g/L for the 90-day readmission of TJA patients [21]. Furthermore, Kudsk established a preoperative albumin level < 42.5 g/L as an independent determinant for hospitalization and severe postoperative complications [22]. Magovern reported that there is an elevated risk of perioperative transfusions when the preoperative albumin falls below 40 g/L in patients with additional comorbidities [19]. Nelson observed that serum albumin levels below 30 g/L were associated with increased incidence rates of complications, with ORs ranging from 1.68 to 3.58 [20]. Our study further revealed that at serum albumin levels between 30 g/L and 37.3 g/L, the risk of perioperative transfusion increased by 1.63 times compared to that in the normal serum albumin group. Hence, surgeons need to be vigilant when the preoperative serum albumin drops below 37.3 g/L in TJA patients.

Cavazos identified preoperative albumin levels as a risk factor associated with transfusion rates in TKA patients [17]. However, they only proposed a relation between albumin and perioperative blood transfusions without exploring the specific connection between albumin levels and perioperative blood transfusions. Hur observed a fourfold increase in the likelihood of receiving transfusions for patients with hypoproteinemia (< 3.5 g/dL) [23] undergoing UKA surgeries [18]. Similarly, Nelson noted a 1.56 times higher likelihood of transfusion in TKA patients with low serum albumin [20]. Consistent with these findings, our study revealed that TJA patients with low albumin levels exhibited an overall 1.83 times higher risk of perioperative transfusions.

Most studies report an association between albumin levels and blood transfusion. However, the study by Itagaki et al., which involved 23 patients with severe limb injuries, found no significant association between albumin levels and perioperative blood transfusion [24]. Due to the small sample size and the specific focus on patients with acute severe trauma, the generalizability and reliability of these findings may be limited.

The reasons for increased perioperative transfusion risk due to lower preoperative albumin

Our patient population showed a 38.16% prevalence of serum albumin below 37.3 g/L, a common finding in individuals undergoing TJA, who often present high-risk characteristics related to nutritional imbalances. Generally, our TJA patients were older, had multiple comorbidities and reduced mobility. Reports indicate that malnutrition prevalence among TJA recipients varies widely, ranging from 8.5 to 50% [25, 26], with its occurrence escalating with advancing age [27]. Multiple factors contributed to the low albumin levels observed in our patients. First, chronic inflammation plays a significant role. Patients with OA and RA in our cohort often suffered from end-stage conditions, characterized by prolonged disease durations spanning several years to decades. These conditions typically involve systemically and locally detectable concentrations of inflammatory mediators [28–30]. Tumor necrosis factor (TNF) and interleukin-6-mediated inflammation might impact hepatic albumin gene transcription [31], while inhibitory substances linked to the inflammatory state, such as TNF and interleukin-1(IL-1), can disrupt albumin synthesis [32]. Additionally, inflammation can significantly increase albumin permeability at the blood-joint barrier, causing substantial albumin uptake [33], thereby contributing to reduced serum albumin levels. Second, distinct dietary habits, with a preference for carbohydrate-rich diets in Asian populations compared to meat-centric Western diets, could explain the lower preoperative serum albumin levels among Asians [34]. Last, in TJA patients with fractures, the cause of decreased albumin levels may also stem from posttraumatic metabolic activation, leading to a catabolic state that results in albumin depletion [35].

There are three key reasons for the impact of decreased serum albumin on the heightened risk of perioperative transfusions. First, as demonstrated by Rasmussen, reduced albumin levels can impair clotting ability, leading to increased bleeding during major noncardiac surgeries [36]. Second, albumin plays a crucial role in maintaining osmotic pressure inside and outside blood vessels. Decreased serum albumin levels may result in a reduced effective blood volume within the vessels, leading to a more significant decline in hemoglobin levels following the same amount of bleeding in affected patients [37]. Hence, individuals with lower albumin levels experience a faster drop in hemoglobin compared to those with normal albumin levels when faced with an equivalent blood loss scenario [38]. Finally, Röhrig discovered a modest to moderate correlation between albumin and hemoglobin levels, increasing the likelihood of hypoproteinemia patients developing anemia by 2.6 times [39]. Consequently, individuals with hypoproteinemia are at an increased risk of developing anemia, consequently elevating the likelihood of requiring perioperative transfusion [13].

The necessity of preoperative optimization of albumin in TJA patients

Patients receiving blood transfusions during TJA experience significantly longer hospital stays than those who do not receive transfusions [17]. In addition to the risk of viral transmission, transfusion reactions, and immunosuppression [12], transfusions can also lead to elevated postoperative mortality rates [9] and other adverse complications. Consequently, addressing patients’ preoperative nutritional status becomes imperative. Statz revealed that optimization of the preoperative nutritional status in THA patients decreased the likelihood of infection or complications by over twofold compared to that in THA patients without preoperative optimization [40]. Burgess emphasized the potential benefits of optimizing preoperative nutritional status in mitigating surgical stress responses, especially in malnourished, frail, or elderly individuals [41]. Johnson recommended that elective surgery be postponed for malnutrition (< 35 g/L) and that the patients should be referred to a nutritionist for optimization until the serum albumin exceeds 35 g/L [42]. Our findings suggest that preoperative albumin transfusions may benefit patients with hypoproteinemia. However, due to the high cost and potential risks associated with allergic reactions, renal dysfunction, and cardiac complications, it is wise to recommend albumin transfusions for only high-risk patients, particularly elderly individuals undergoing TJA [43, 44]. After nutritional support begins, the serum albumin concentration gradually returns to normal after three weeks [45]. Given that albumin has a half-life of 20 days, reflecting dietary intake from the previous 3 weeks [25], optimizing albumin levels through nutritional support one month prior to elective TJA surgery is a reasonable and feasible option for our cohort of end-stage OA patients undergoing nonemergency surgeries.

Nonetheless, this investigation has certain limitations. Firstly, its retrospective nature and the presence of incomplete data in certain cases present challenges. Despite our efforts to minimize sample loss during the matching process, a small proportion of cases (6.8%) were not included in the final analysis, which may impact the generalizability of our findings. Additionally, as a single-center study, further validation with a larger sample size is needed. Finally, the role of preoperative nutritional support for TJA patients and its potential benefits for minimizing perioperative blood transfusions require additional research.

Conclusion

In patients TJA, low preoperative serum albumin levels have been linked to a higher risk of perioperative blood transfusion. Moreover, a clear dose‒response relationship exists: the lower the preoperative serum albumin level, the higher the risk of requiring a blood transfusion during surgery. These findings suggest that preoperative serum albumin levels could serve as a predictive factor for blood transfusion risk in TJA patients.

Abbreviations

AUC Area under the curve

BMI Body Mass Index

CHD Coronary heart disease

CI confidence interval

COPD Chronic obstructive pulmonary disease

IL-1 Interleukin-1

IL-17 Interleukin-17

IL-6 Interleukin-6

OA Osteoarthritis

OR Odds ratio

PSM propensity score matching

RA Rheumatoid Arthritis

ROC Receiver operator characteristic

THA Total Hip Arthroplasty

TKA Total Knee Arthroplasty

TJA total joint arthroplasty

TNF Tumor Necrosis Factor

TP Total serum protein

UKA Unicompartmental knee arthroplasty

Acknowledgements

Not applicable.

Author contributions

SLX, XJX, TL, PH and QXM contributed to the conception and design of the study. SLX and TL contributed to the acquisition of data. PH and QXM contributed to analysis and interpretation of data. XJX wrote the manuscript. All authors read and approved the final manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author or first author on reasonable request.

Declarations

Ethics approval and consent to participate

This study has been approved the Ethics Committee of Army Medical Center of PLA; ratification number is 2021(288). Because this was a retrospective study, informed consent was waived by the Ethics Committee of Army Medical Center of PLA.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Shenglian Xu and Xiaojuan Xiong contributed equally to this work.
==== Refs
References

1. Driesman A Paoli AR Wiznia DH Total joint arthroplasty is Associated with a decreased risk of traumatic falls: an analysis of 499,094 cases J Am Acad Orthop Surg 2020 28 20 838 46 10.5435/JAAOS-D-19-00541 31834037
Driesman A, Paoli AR, Wiznia DH, et al. Total joint arthroplasty is Associated with a decreased risk of traumatic falls: an analysis of 499,094 cases. J Am Acad Orthop Surg. 2020;28(20):838–46. 10.5435/JAAOS-D-19-00541.31834037 10.5435/JAAOS-D-19-00541
2. Jasper LL Jones CA Mollins J Pohar SL Beaupre LA Risk factors for revision of total knee arthroplasty: a scoping review BMC Musculoskelet Disord 2016 17 182 10.1186/s12891-016-1025-8 27113334
Jasper LL, Jones CA, Mollins J, Pohar SL, Beaupre LA. Risk factors for revision of total knee arthroplasty: a scoping review. BMC Musculoskelet Disord. 2016;17:182. 10.1186/s12891-016-1025-8. Published 2016 Apr 26.27113334 10.1186/s12891-016-1025-8
3. Kurtz S Ong K Lau E Mowat F Halpern M Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 J Bone Joint Surg Am 2007 89 4 780 5 10.2106/JBJS.F.00222 17403800
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5. 10.2106/JBJS.F.00222.17403800 10.2106/JBJS.F.00222
4. Walsh TS Palmer J Watson D Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion Br J Anaesth 2012 108 1 63 71 10.1093/bja/aer326 22037224
Walsh TS, Palmer J, Watson D, et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth. 2012;108(1):63–71. 10.1093/bja/aer326.22037224 10.1093/bja/aer326
5. Ke-Rong D. Twenty-year accelerated development of artificial joints in China. Chin J Joint Surg. 2015:691–4.
6. Ponnusamy KE Kim TJ Khanuja HS Perioperative blood transfusions in orthopaedic surgery J Bone Joint Surg Am 2014 96 21 1836 44 10.2106/JBJS.N.00128 25378512
Ponnusamy KE, Kim TJ, Khanuja HS. Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am. 2014;96(21):1836–44. 10.2106/JBJS.N.00128.25378512 10.2106/JBJS.N.00128
7. Pennestrì F Maffulli N Sirtori P Blood management in fast-track orthopedic surgery: an evidence-based narrative review J Orthop Surg Res 2019 14 1 263 10.1186/s13018-019-1296-5 31429775
Pennestrì F, Maffulli N, Sirtori P, et al. Blood management in fast-track orthopedic surgery: an evidence-based narrative review. J Orthop Surg Res. 2019;14(1):263. 10.1186/s13018-019-1296-5. Published 2019 Aug 20.31429775 10.1186/s13018-019-1296-5
8. Menendez ME Lu N Huybrechts KF Variation in Use of blood transfusion in primary total hip and knee arthroplasties J Arthroplasty 2016 31 12 2757 e27632 10.1016/j.arth.2016.05.022 27325367
Menendez ME, Lu N, Huybrechts KF, et al. Variation in Use of blood transfusion in primary total hip and knee arthroplasties. J Arthroplasty. 2016;31(12):2757–e27632. 10.1016/j.arth.2016.05.022.27325367 10.1016/j.arth.2016.05.022
9. Engoren M Mitchell E Perring P Sferra J The effect of erythrocyte blood transfusions on survival after surgery for hip fracture J Trauma 2008 65 6 1411 5 10.1097/TA.0b013e318157d9f9 19077635
Engoren M, Mitchell E, Perring P, Sferra J. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture. J Trauma. 2008;65(6):1411–5. 10.1097/TA.0b013e318157d9f9.19077635 10.1097/TA.0b013e318157d9f9
10. Carson JL Altman DG Duff A Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair Transfusion 1999 39 7 694 700 10.1046/j.1537-2995.1999.39070694.x 10413276
Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion. 1999;39(7):694–700. 10.1046/j.1537-2995.1999.39070694.x.10413276 10.1046/j.1537-2995.1999.39070694.x
11. Glance LG Dick AW Mukamel DB Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery Anesthesiology 2011 114 2 283 92 10.1097/ALN.0b013e3182054d06 21239971
Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011;114(2):283–92. 10.1097/ALN.0b013e3182054d06.21239971 10.1097/ALN.0b013e3182054d06
12. Perkins HA Busch MP Transfusion-associated infections: 50 years of relentless challenges and remarkable progress Transfusion 2010 50 10 2080 99 10.1111/j.1537-2995.2010.02851.x 20738828
Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion. 2010;50(10):2080–99. 10.1111/j.1537-2995.2010.02851.x.20738828 10.1111/j.1537-2995.2010.02851.x
13. Xiong X et al. Dec. Correlation of the severity of anemia in patients undergoing total joint arthroplasty with preoperative deep vein thrombosis: a retrospective cohort study. Journal of orthopaedic surgery and research vol. 17,1 554. 20 2022, 10.1186/s13018-022-03457-y
14. Cabrerizo S Cuadras D Gomez-Busto F Artaza-Artabe I Marín-Ciancas F Malafarina V Serum albumin and health in older people: review and meta analysis Maturitas 2015 81 1 17 27 10.1016/j.maturitas.2015.02.009 25782627
Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marín-Ciancas F, Malafarina V. Serum albumin and health in older people: review and meta analysis. Maturitas. 2015;81(1):17–27. 10.1016/j.maturitas.2015.02.009.25782627 10.1016/j.maturitas.2015.02.009
15. Oettl K Stauber RE Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br J Pharmacol 2007 151 5 580 90 10.1038/sj.bjp.0707251 17471184
Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007;151(5):580–90. 10.1038/sj.bjp.0707251.17471184 10.1038/sj.bjp.0707251
16. Becker BF Jacob M Leipert S Salmon AH Chappell D Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases Br J Clin Pharmacol 2015 80 3 389 402 10.1111/bcp.12629 25778676
Becker BF, Jacob M, Leipert S, Salmon AH, Chappell D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol. 2015;80(3):389–402. 10.1111/bcp.12629.25778676 10.1111/bcp.12629
17. Cavazos DR Sayeed Z Court T Chen C Little BE Darwiche HF Predicting factors for blood transfusion in primary total knee arthroplasty using a machine learning method J Am Acad Orthop Surg 2023 31 19 e845 58 10.5435/JAAOS-D-23-00063 37733328
Cavazos DR, Sayeed Z, Court T, Chen C, Little BE, Darwiche HF. Predicting factors for blood transfusion in primary total knee arthroplasty using a machine learning method. J Am Acad Orthop Surg. 2023;31(19):e845–58. 10.5435/JAAOS-D-23-00063.37733328 10.5435/JAAOS-D-23-00063
18. Hur ES Bohl DD Della Valle CJ Villalobos F Gerlinger TL Hypoalbuminemia predicts adverse events following unicompartmental knee arthroplasty J Knee Surg 2023 36 5 491 7 10.1055/s-0041-1739146 34768290
Hur ES, Bohl DD, Della Valle CJ, Villalobos F, Gerlinger TL. Hypoalbuminemia predicts adverse events following unicompartmental knee arthroplasty. J Knee Surg. 2023;36(5):491–7. 10.1055/s-0041-1739146.34768290 10.1055/s-0041-1739146
19. Magovern JA Sakert T Benckart DH Burkholder JA Liebler GA Magovern Sr GJ A model for predicting transfusion after coronary artery bypass grafting Ann Thorac Surg 1996 61 1 27 32 10.1016/0003-4975(95)00808-X 8561579
Magovern JA, Sakert T, Benckart DH, Burkholder JA, Liebler GA, Magovern Sr GJ, et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg. 1996;61(1):27–32. 10.1016/0003-4975(95)00808-X.8561579 10.1016/0003-4975(95)00808-X
20. Nelson CL Elkassabany NM Kamath AF Liu J Low albumin levels, more than morbid obesity, are Associated with complications after TKA Clin Orthop Relat Res 2015 473 10 3163 72 10.1007/s11999-015-4333-7 25995174
Nelson CL, Elkassabany NM, Kamath AF, Liu J. Low albumin levels, more than morbid obesity, are Associated with complications after TKA. Clin Orthop Relat Res. 2015;473(10):3163–72. 10.1007/s11999-015-4333-7.25995174 10.1007/s11999-015-4333-7
21. Black CS Goltz DE Ryan SP The role of Malnutrition in ninety-day outcomes after total joint arthroplasty J Arthroplasty 2019 34 11 2594 600 10.1016/j.arth.2019.05.060 31239176
Black CS, Goltz DE, Ryan SP, et al. The role of Malnutrition in ninety-day outcomes after total joint arthroplasty. J Arthroplasty. 2019;34(11):2594–600. 10.1016/j.arth.2019.05.060.31239176 10.1016/j.arth.2019.05.060
22. Kudsk KA Tolley EA DeWitt RC Preoperative albumin and surgical site identify surgical risk for major postoperative complications JPEN J Parenter Enter Nutr 2003 27 1 1 9 10.1177/014860710302700101
Kudsk KA, Tolley EA, DeWitt RC, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enter Nutr. 2003;27(1):1–9. 10.1177/014860710302700101.10.1177/014860710302700101
23. Jaberi FM Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty Clin Orthop Relat Res Vol 2008 466 1368 71 10.1007/s11999-008-0214-7
Jaberi FM, et al. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res Vol. 2008;466:1368–71. 10.1007/s11999-008-0214-7.10.1007/s11999-008-0214-7
24. Itagaki Y et al. Jan. Early administration of fibrinogen concentrate is associated with improved survival among severe trauma patients: a single-centre propensity score-matched analysis. World journal of emergency surgery: WJES vol. 15 7. 14 2020, 10.1186/s13017-020-0291-9
25. Sayeed Z Anoushiravani AA Simha S Markers for malnutrition and BMI status in total joint arthroplasty and pharmaconutrient therapy JBJS Rev 2019 7 5 e3 10.2106/JBJS.RVW.18.00056 31094890
Sayeed Z, Anoushiravani AA, Simha S, et al. Markers for malnutrition and BMI status in total joint arthroplasty and pharmaconutrient therapy. JBJS Rev. 2019;7(5):e3. 10.2106/JBJS.RVW.18.00056.31094890 10.2106/JBJS.RVW.18.00056
26. Morey VM Song YD Whang JS Kang YG Kim TK Can serum Albumin Level and Total Lymphocyte Count be surrogates for malnutrition to Predict Wound complications after total knee arthroplasty? J Arthroplasty 2016 31 6 1317 21 10.1016/j.arth.2015.12.004 26753608
Morey VM, Song YD, Whang JS, Kang YG, Kim TK. Can serum Albumin Level and Total Lymphocyte Count be surrogates for malnutrition to Predict Wound complications after total knee arthroplasty? J Arthroplasty. 2016;31(6):1317–21. 10.1016/j.arth.2015.12.004.26753608 10.1016/j.arth.2015.12.004
27. O’Connor MI Bernstein J Huff T Movement is life—an serum albumin level and total lymphocyte count be surrogates for malnutritio: malnutrition disparities J Am Acad Orthop Surg 2021 30 1007 10 34898522
O’Connor MI, Bernstein J, Huff T. Movement is life—an serum albumin level and total lymphocyte count be surrogates for malnutritio: malnutrition disparities. J Am Acad Orthop Surg. 2021;30:1007–10.34898522
28. Hufman KM Kraus WE Osteoarthritis and the metabolic syndrome: more evidence that the etiology of OA is diferent in men and women Osteoarthr Cartil 2012 20 7 603 4 10.1016/j.joca.2012.04
Hufman KM, Kraus WE. Osteoarthritis and the metabolic syndrome: more evidence that the etiology of OA is diferent in men and women. Osteoarthr Cartil. 2012;20(7):603–4. 10.1016/j.joca.2012.04.10.1016/j.joca.2012.04
29. Babaei M, Javadian Y, Narimani H, Ranaei M, Heidari B, Basereh H, Gholinia H, Firouzjahi A. Correlation between systemic markers of inflammation and local synovitis in knee osteoarthritis. Caspian J Intern Med. 2019 Fall;10(4):383–387. 10.22088/cjim.10.4.383
30. Kim KW Kim HR Kim BM Cho ML Lee SH Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis Am J Pathol 2015 185 11 3011 24 10.1016/j.ajpath.2015.07.017 26362732
Kim KW, Kim HR, Kim BM, Cho ML, Lee SH. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Am J Pathol. 2015;185(11):3011–24. 10.1016/j.ajpath.2015.07.017.26362732 10.1016/j.ajpath.2015.07.017
31. Chojkier M Inhibition of albumin synthesis in chronic diseases: molecular mechanisms J Clin Gastroenterol 2005 39 4 Suppl 2 S143 6 10.1097/01.mcg.0000155514.17715.39 15758650
Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol. 2005;39(4 Suppl 2):S143–6. 10.1097/01.mcg.0000155514.17715.39.15758650 10.1097/01.mcg.0000155514.17715.39
32. Dinarello CA Interleukin-1 and the pathogenesis of the acute-phase response N Engl J Med 1984 311 22 1413 8 10.1056/NEJM198411293112205 6208485
Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med. 1984;311(22):1413–8. 10.1056/NEJM198411293112205.6208485 10.1056/NEJM198411293112205
33. Kratz F Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J Control Release 2008 132 3 171 83 10.1016/j.jconrel.2008.05.010 18582981
Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008;132(3):171–83. 10.1016/j.jconrel.2008.05.010.18582981 10.1016/j.jconrel.2008.05.010
34. Cao G Huang Q Xu B Huang Z Xie J Pei F Multimodal Nutritional Management in primary total knee arthroplasty: a Randomized Controlled Trial J Arthroplast 2017 32 11 3390 5 10.1016/j.arth.2017.06.020
Cao G, Huang Q, Xu B, Huang Z, Xie J, Pei F. Multimodal Nutritional Management in primary total knee arthroplasty: a Randomized Controlled Trial. J Arthroplast. 2017;32(11):3390–5. 10.1016/j.arth.2017.06.020.10.1016/j.arth.2017.06.020
35. Gillis G Wischmeyer C Pre-operative nutrition and the elective surgical patient: why, how and what? Anaesthesia 2019 74 Suppl 1 27 35 10.1111/anae.14506 30604414
Gillis G, Wischmeyer C. Pre-operative nutrition and the elective surgical patient: why, how and what? Anaesthesia. 2019;74(Suppl 1):27–35. 10.1111/anae.14506.30604414 10.1111/anae.14506
36. Rasmussen KC Højskov M Johansson PI Impact of Albumin on Coagulation competence and hemorrhage during major surgery: a Randomized Controlled Trial Med (Baltim) 2016 95 9 e2720 10.1097/MD.0000000000002720
Rasmussen KC, Højskov M, Johansson PI, et al. Impact of Albumin on Coagulation competence and hemorrhage during major surgery: a Randomized Controlled Trial. Med (Baltim). 2016;95(9):e2720. 10.1097/MD.0000000000002720.10.1097/MD.0000000000002720
37. Karaahmet F Coban S Yuksel I Gastrointestinal bleeding and transfusion strategies in patients with hypoalbuminemia Dig Dis Sci 2014 59 2 493 10.1007/s10620-013-2997-y 24385010
Karaahmet F, Coban S, Yuksel I. Gastrointestinal bleeding and transfusion strategies in patients with hypoalbuminemia. Dig Dis Sci. 2014;59(2):493. 10.1007/s10620-013-2997-y.24385010 10.1007/s10620-013-2997-y
38. Kim K Seo H Chin JH Son HJ Hwang JH Kim YK Preoperative hypoalbuminemia and anemia as predictors of transfusion in radical nephrectomy for renal cell carcinoma: a retrospective study BMC Anesthesiol 2015 15 103 10.1186/s12871-015-0089-6 26194797
Kim K, Seo H, Chin JH, Son HJ, Hwang JH, Kim YK. Preoperative hypoalbuminemia and anemia as predictors of transfusion in radical nephrectomy for renal cell carcinoma: a retrospective study. BMC Anesthesiol. 2015;15:103. 10.1186/s12871-015-0089-6.26194797 10.1186/s12871-015-0089-6
39. Röhrig G Becker I Polidori MC Schulz RJ Noreik M Association of anemia and hypoalbuminemia in German geriatric inpatients: relationship to nutritional status and comprehensive geriatric assessment Z Gerontol Geriatr 2015 48 7 619 24 10.1007/s00391-015-0872-5 25877770
Röhrig G, Becker I, Polidori MC, Schulz RJ, Noreik M. Association of anemia and hypoalbuminemia in German geriatric inpatients: relationship to nutritional status and comprehensive geriatric assessment. Z Gerontol Geriatr. 2015;48(7):619–24. 10.1007/s00391-015-0872-5.25877770 10.1007/s00391-015-0872-5
40. Statz JM Odum SM Johnson NR Otero JE Failure to medically optimize before total hip arthroplasty: which modifiable risk factor is the most dangerous? Arthroplast Today 2021 10 18 23 10.1016/j.artd.2021.05.021 34277906
Statz JM, Odum SM, Johnson NR, Otero JE. Failure to medically optimize before total hip arthroplasty: which modifiable risk factor is the most dangerous? Arthroplast Today. 2021;10:18–23. 10.1016/j.artd.2021.05.021. Published 2021.34277906 10.1016/j.artd.2021.05.021
41. Burgess LC Phillips SM Wainwright TW What is the role of nutritional supplements in support of total hip replacement and total knee replacement surgeries? A systematic review Nutrients 2018 10 7 820 10.3390/nu10070820 29941852
Burgess LC, Phillips SM, Wainwright TW. What is the role of nutritional supplements in support of total hip replacement and total knee replacement surgeries? A systematic review. Nutrients. 2018;10(7):820. 10.3390/nu10070820. Published 2018 Jun 25.29941852 10.3390/nu10070820
42. Johnson NR Statz JM Odum SM Otero JE Failure to optimize before total knee arthroplasty: which modifiable risk factor is the most dangerous? J Arthroplast 2021 36 7 2452 7 10.1016/j.arth.2021.02.061
Johnson NR, Statz JM, Odum SM, Otero JE. Failure to optimize before total knee arthroplasty: which modifiable risk factor is the most dangerous? J Arthroplast. 2021;36(7):2452–7. 10.1016/j.arth.2021.02.061.10.1016/j.arth.2021.02.061
43. Rudasill SE Ng A Kamath AF Preoperative Serum Albumin Levels Predict Treatment Cost in total hip and knee arthroplasty Clin Orthop Surg 2018 10 4 398 406 10.4055/cios.2018.10.4.398 30505406
Rudasill SE, Ng A, Kamath AF. Preoperative Serum Albumin Levels Predict Treatment Cost in total hip and knee arthroplasty. Clin Orthop Surg. 2018;10(4):398–406. 10.4055/cios.2018.10.4.398.30505406 10.4055/cios.2018.10.4.398
44. Suarez JI Martin RH Hohmann SF Human albumin use in adults in U.S. Academic Medical centers Crit Care Med 2017 45 1 e16 22 10.1097/CCM.0000000000002010 27632679
Suarez JI, Martin RH, Hohmann SF, et al. Human albumin use in adults in U.S. Academic Medical centers. Crit Care Med. 2017;45(1):e16–22. 10.1097/CCM.0000000000002010.27632679 10.1097/CCM.0000000000002010
45. Helms RA Dickerson RN Ebbert ML Christensen ML Herrod HG Retinol-binding protein and prealbumin: useful measures of protein repletion in critically ill, malnourished infants J Pediatr Gastroenterol Nutr 1986 5 4 586 92 3090221
Helms RA, Dickerson RN, Ebbert ML, Christensen ML, Herrod HG. Retinol-binding protein and prealbumin: useful measures of protein repletion in critically ill, malnourished infants. J Pediatr Gastroenterol Nutr. 1986;5(4):586–92.3090221
